Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      Homebiopharmaceutical

      biopharmaceutical

      Merck Stock: Keytruda’s Success in Oncology and Other Opportunities
      Investing News

      Merck Stock: Keytruda’s Success in Oncology and Other Opportunities

      June 6, 2023
      Pfizer Stock Rises on Oral Weight Loss Medication Peer-Reviewed Data
      Investing News

      Pfizer Stock Rises on Oral Weight Loss Medication Peer-Reviewed Data

      May 22, 2023
      Pfizer Stock: Investors should consider Pfizer, Amgen, and These Seven Other Low-Priced Healthcare Stocks
      Trading Tips

      Pfizer Stock: Investors should consider Pfizer, Amgen, and These Seven Other Low-Priced Healthcare Stocks

      May 18, 2023
      Pfizer Stock: Pfizer is Performing the Fourth-Largest Deal in History When It Sells $31 Billion Worth of Bonds
      Investing News

      Pfizer Stock: Pfizer is Performing the Fourth-Largest Deal in History When It Sells $31 Billion Worth of Bonds

      May 16, 2023
      Pfizer Stock Rose as Q1 Results Focused on M&A, Rsv Vaccine Race
      Investing News

      Pfizer Stock Rose as Q1 Results Focused on M&A, Rsv Vaccine Race

      May 1, 2023
      Moderna Stock Falls as Flu Vaccine Misses Early Success Criteria; Study Continues
      Investing News

      Moderna Stock Falls as Flu Vaccine Misses Early Success Criteria; Study Continues

      April 11, 2023
      Merck Stock Rose Slightly After Eisai and Merck Ended Two Keytruda Combo Studies After Missing Primary Targets
      Investing News

      Merck Stock Rose Slightly After Eisai and Merck Ended Two Keytruda Combo Studies After Missing Primary Targets

      April 7, 2023
      Pfizer Stock: The Good and the Bad of mRNA Vaccines
      Investing News

      Pfizer Stock: The Good and the Bad of mRNA Vaccines

      March 23, 2023
      Moderna Stock Fell After CEO Bancel Told Lawmakers COVID Vaccination Price Rises Are Justified
      Investing News

      Moderna Stock Fell After CEO Bancel Told Lawmakers COVID Vaccination Price Rises Are Justified

      March 22, 2023
      Pfizer Stock Fell Despite Its COVID Pill’s Effectiveness Against Omicron
      Investing News

      Pfizer Stock Fell Despite Its COVID Pill’s Effectiveness Against Omicron

      March 14, 2023
      « 1 2 3 4 … 17 »

       

      LATEST NEWS

      • Investing News Beta Technologies Q3 IPO Insights
      • Investing News Salesforce Reports Robust Q3 2026 Earnings
      • Investing News Salesforce’s Stock Boost Amid Raised Guidance
      • Investing News Macy’s Q3 2025 Earnings Overview
      • Investing News Okta’s Strong Q3 2026 Earnings Boost Shares

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025